Record quarter validates strategy; guidance held conservative amid cyclical strength
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade A
On track for FY27 ₹2,500 Cr target; no prior guidance missed; delivered record quarter. Maintained margin guidance despite beating—signals disciplined execution, not sandbagging.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Garware delivered a record quarter with 27.9% revenue growth and 59.8% PAT growth, driven by structural product mix shift (architectural 25%, high-end sun control). Capex pipeline (TPU Q3 FY27, SCF H1 FY28) and D2C expansion (250+ GAS, 50 target GHS by FY27 end) are concrete. Key risk: Management maintained conservative FY27 guidance (₹2,500 Cr) despite beat, signaling Q1 margins are cyclically high; supply chain headwinds (Middle East war) are capping PPF utilization.
₹633.1 Cr
Revenue · +27.9% YoY₹132.7 Cr
Reported PAT · +59.8% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue 633 Cr, growing 28% YoY
METDelivered 633.1 Cr, +27.9% YoY
PAT grew 60% YoY to 133 Cr
METDelivered 132.7 Cr, +59.8% YoY
EBITDA margin 30.3%, expanding 544 bps
METMargin is record high; prior Q1 implied ~25.8% → plausible 544 bps
Margins are structural, not exceptional
OVERSTATED30.3% exceeds 25% ±2% guidance; mgmt claims cyclical (Q1 peak, Q3 lower)
FY27 target ₹2,500 Cr achievable
METQ1 ₹633 Cr = 25% of target; needs ~₹1,867 Cr Q2–Q4 (~6% seq. growth)
Earnings quality
What changed since the last call
Architectural segment now 25% of revenue
UpgradeWas 5% historically; structural shift toward high-end, high-margin (>25%) products. Demonstrates market-creation success.
Gross margin to ~60%, EBITDA to 30.3%
UpgradeQ1 FY26 implied ~25.8% EBITDA; Q1 FY27 30.3% = +544 bps. Driven by product mix + higher-end IR products (99% heat rejection).
D2C revenue trajectory accelerating
UpgradeGAS 250+ studios, GHS 9 studios (targeting 50 FY27 end); PPF US e-commerce growing; D2C can exceed ₹100 Cr (prior ₹200 Cr estimate now says 'bigger').
Supply chain headwinds (Middle East war)
DowngradeJebel Ali ship delays capped PPF volumes; new line utilization at 60% vs 100% potential. Recoverable but near-term drag.
FY27 revenue & margin guidance reaffirmed
NeutralNo change: ₹2,500 Cr+ revenue, 25% ±2% EBITDA margin. Despite beat, guidance held—signals conservatism, not complacency.
The Q&A
Analysts pressed hard on margin sustainability: Is 60% gross margin permanent or cyclical Q1 peak? Management defended (product mix + strategic high-end focus) but hedged (Q3 will be lower). On guidance: Why not raise despite beat? Answer: We are conservative; unexpected events happen. On bottlenecks: Is it capacity, distribution, or applicator availability? Management: It's market education; TAM is big but needs creation. Overall tone held steady; no signs of wavering under pressure.
Gross margin sustainability — Viraj Parekh, Carnelian AMC
AnsweredQ1 is strong seasonally; product mix (high-IR sun control, architectural 25%) drives it. Q2 similar, Q3 lower. Overall trend improving but not flat 60%.
Tariff refund timing — Aman, Stallion Asset
AnsweredQ1 has zero impact. Received 30–40% so far (Jul–Aug). Expect full receipt in Q2, ~₹50 Cr net to company after customer sharing.
D2C growth trajectory — Aman, Stallion Asset
AnsweredYes, confident ₹2,500 Cr FY27 and 15–20% CAGR ongoing. D2C + antidumping + premium mix driving it. 3–4 years → ₹3,500 Cr possible.
Architectural product margin — Swechha Jain, ANS Wealth
PartialArchitectural margins definitely north of 25%. TPU adds 1.5–2% (FY28). But we guide 25% ±2% conservatively to maintain credibility.
New capex contribution in FY27 — Deepak Ajmera, IGE India
AnsweredTPU is 75% backward integration (PPF margin lift) + 25% new products (early stage). SCF comes H1 FY28. No material volume this year; growth is sequential.
Market bottleneck for faster growth — Nikhil Chaudhary, Toro Wealth Managers
AnsweredIt's market education. Consumers don't know films can replace glass. We're educating government bodies (75 people in one dept visit). Capex is not the bottleneck.
GHS revenue and model — Swechha Jain, ANS Wealth
PartialGHS is miniscule, very new (9 studios). Fully company-controlled, all revenues flow to company (not distributor model). Target 50 studios FY27 end; details later.
Channel partner resistance to D2C — Pratham Kankariya, Quantum AMC
AnsweredSome resistance, yes. But we educated them; their business is better than before. GHS products are different (not cannibalising PPF). Win-win set up.
R&D spend as % of sales — Gopalakrishnan, Uthranush Investments
Partial3–5% of revenues. Varies because some R&D gets embedded in manufacturing. Real number hard to isolate.
Cash deployment (dividend, buyback, capex) — Ishit Desai, Fods Family Office
PartialEvaluating inorganic growth. Priority: More capex for backward/forward integration (quality control). D2C growth will follow. Details in couple of months.
Guidance
FY27 ₹2,500 Cr+
HighReaffirmed; Q1 ₹633 Cr = 25% of target. Needs ~₹1,867 Cr Q2–Q4 (~6% seq. growth), achievable given momentum.
EBITDA 25% ±2% (23–27% range)
MediumQ1 at 30.3% exceeds range significantly. Mgmt claims cyclical (Q1 peak, Q3 lower). FY27 blended margin likely 26–28% range, above guidance midpoint but below Q1.
TPU Q3 FY27; SCF H1 FY28 (₹192 Cr announced)
HighOn track per management. TPU adds 1.5–2% margin (FY28). SCF ₹500–550 Cr capacity; no revenue this year.
Risks the call surfaced
Supply chain geopolitical
MediumMiddle East conflict impacting deliveries; ship stuck in Jebel Ali. PPF new line at 60% utilization; recoverable but near-term volume loss.
Market adoption & education
MediumArchitectural films and TPU products require consumer/market education. TAM is large (~₹1,000 Cr for TPU) but 'needs to be created.' GHS at 9 studios; scaling to 50 by FY27 end is aggressive.
Margin cyclicality
MediumQ1 EBITDA 30.3% exceeds guidance 25% ±2% significantly. Summer seasonality + product mix. Q3 expected 'a little lower' per management. If FY27 blended margin falls below 25%, guidance miss risk.
Capex execution
Low₹700+ Cr invested over past years; new ₹192 Cr SCF line announced. Any delays would push contribution to FY28+; cost overruns would compress margins.
Customer concentration
Low5 OEM PPF relationships; GAS reliant on distributor network; GHS on home furnishing partners. Management withheld specifics on concentration.
Management
Score 7/10. Transparent on product mix drivers, supply chain headwinds, margin cyclicality. Defended conservatism in guidance despite beat. Withheld some competitive strategy details (requested one-on-one IR meetings). No obvious evasions. Strong track record: FY27 ₹2,500 Cr revenue on pace (Q1 = 25% of target); ₹700+ Cr capex deployed over years; debt-free balance sheet. Capex timelines (TPU Q3, SCF H1 FY28) reaffirmed and appear on track.
1 · Q3 FY27 (Oct–Dec 2026)
TPU line commissioning; 75% PPF backward integration, 25% new products
2 · H1 FY28 (Apr–Sep 2027)
SCF line launches; ₹500–550 Cr peak capacity; automated/robotic
3 · FY27 (by Jun 2027)
GHS studio expansion to 50 locations (from 9); D2C scaling
Key risk: Management maintained conservative FY27 guidance (₹2,500 Cr) despite beat, signaling Q1 margins are cyclically high; supply chain headwinds (Middle East war) are capping PPF utilization.
Record ₹633 Crore Quarter Bumps Into Cyclical Reality
Revenue and profit hit all-time highs, but EBITDA margins peaked with summer seasonality. Management reaffirmed guidance rather than raising it, signaling that Q1's 30.3% margin is a cyclical peak, not a new baseline.
₹633.1 Cr
+27.9% YoY · highest ever
₹132.7 Cr
+59.8% YoY · highest ever
30.3%
+544 bps · guidance is 25% ±2%
On the headline, Garware delivered a blowout. Revenue of ₹633 crore and net profit of ₹133 crore are the highest the company has ever posted, growing 28% and 60% respectively year-over-year. EBITDA margin hit 30.3%, a record 544 basis points ahead of the prior year. But the stock fell 4.98% on day 1 post-result announcement and recovered only to down 1.48% by day 5. The reason is in the fine print: management reaffirmed its full-year guidance of ₹2,500 crore+ revenue and 25% ±2% EBITDA margin, rather than lifting it. The beat is real. The quarter is genuine. But it is also a cyclical peak, not a new baseline. The market understood this immediately.
Why the margins won't hold here
The company is explicit: Q1 is strong seasonally, driven by summer demand for sun control films (55% of revenue, typically premium-priced). The product mix—architectural films now 25% of revenue (up from 5% historically), high-end infrared sun control products (99% heat rejection)—amplified the margin tailwind. This is real, and it is structural. But Q1's 30.3% EBITDA margin is not a run-rate. Management says Q2 will be similar, and Q3 will be "a little lower." Gross margin hovers around 60% today; that too will normalize. The company is disciplining itself not to chase every quarterly beat. FY27 guidance assumes a blended margin closer to 26–28% across all four quarters—above the guided midpoint of 25% but well below Q1's peak.
While this quarter margin performance has been exceptional, our focus remains on building a business capable of delivering sustainable industry-leading profitability across business cycles.
Revenue ₹633 Cr, growing 28% YoY
Supported₹633.1 Cr, +27.9% YoY
PAT grew 60% YoY to ₹133 Cr
Supported₹132.7 Cr, +59.8% YoY
EBITDA margin 30.3%, expanding 544 bps
SupportedHighest quarter ever; prior Q1 implied ~25.8%
Margins are structural and sustainable
Overstated30.3% exceeds 25% ±2% guidance; mgmt: Q1 is cyclically strong, Q3 lower
FY27 target ₹2,500 Cr+ is achievable
SupportedQ1 ₹633 Cr = 25% of target; needs ~₹1,867 Cr Q2–Q4 (~6% seq. growth)
What shifted on this call
The structural story is advancing. Architectural films, historically a 5% niche, now represent 25% of revenue—a five-fold rise in strategic importance. These are high-margin products (>25%) used in green building and energy-efficient construction, with room to scale globally. Sun Control Films (55% of revenue) are upgrading to premium infrared products, commanding higher realizations. The D2C network is accelerating: Garware Application Studios (GAS) have grown to 250+ locations in India, and Garware Home Solutions (GHS), a home-furnishing D2C play, is ramping from 9 studios with an ambitious target of 50 by year-end. Paint Protection Films (PPF), down to 20% of mix due to supply-chain delays from the Middle East conflict, are poised to rebound once shipments normalize. Capacity expansions are on track: a TPU (thermoplastic polyurethane) backward-integration line is set to commission in Q3 FY27 (Oct–Dec 2026), with a new Sun Control Film line following in H1 FY28 (₹500–550 crore peak capacity). The near-term headwind is real but recoverable: Middle East geopolitical disruptions capped PPF new-line utilization at 60%; management expects Q2 recovery.
Record quarter validates product-mix strategy and capex deployment over years
Architectural segment (25% of mix) unlocks 15–20% CAGR medium-term runway
FY27 guidance (₹2,500 Cr+) on track; no history of guidance misses
D2C network (250+ GAS, 9 GHS targeting 50) differentiates from competitors
Debt-free with ₹850 Cr cash; capex-funded without dilution
Q1 EBITDA margin (30.3%) is cyclically elevated; Q3 expected lower
Supply-chain delays (Jebel Ali, PPF 60% utilization) recoverable but near-term drag
TPU and architectural markets nascent; require customer education
GHS is miniscule (9 studios); 50-studio target by FY27 end is ambitious
Tariff refunds (~₹50 Cr) flow in Q2, not Q1; one-time, non-structural
Margin cyclicality; Q1 peak may not repeat
HighIf FY27 blended margin falls below 25% guidance floor, it signals product-mix gains are smaller than modeled. This is the core debate; resolves in Q2.
Supply-chain disruption (Middle East conflict, Jebel Ali port)
MediumPPF new-line utilization at 60% vs. 100%. Delays into Q2 limit revenue ramp; recoverable but a real near-term headwind to volumes.
TPU and architectural market creation
MediumBoth segments require customer education. TAM is large (~₹1,000+ crore for TPU) but must be created. Adoption execution risk; not guaranteed.
Capex execution (TPU Q3 FY27, SCF H1 FY28)
Medium₹192 Cr SCF investment and TPU backward integration must deliver on timeline and margin uplift. Any slip pushes contribution to FY28+.
GHS scaling capital intensity
Low9 studios today, target 50 by FY27 end. Revenue is miniscule; capex-heavy startup. Dilutive to group margins short-term if capex outpaces revenue.
FII/DII ownership soft; promoter at 60.7%
LowFII +24 bps QoQ to 4.22%, DII +108 bps to 6.35%. Institutional confidence is modest. No bulk buying at result time; support thesis still proving.
1 · Q2 EBITDA margin sequencing
Does margin stay at 30% or decline to 26–28%? If it holds above 28%, it signals structural tailwind and validates the architectural/product-mix thesis. If it dips to 25%, cyclicality is confirmed and FY27 guidance becomes the real ceiling, not a floor. This single number resolves the quarter's central debate.
2 · Tariff refund flow and quantization
Management said ~₹50 Cr net expected in Q2 (after 30–40% received in Jul–Aug). Confirm actual amount and whether it flows to PAT or is shared with customers. Timing matters for Q2 comparability.
3 · PPF recovery and architectural segment contribution
Supply-chain delays are supposed to be behind by Q2. If PPF volume doesn't recover, it flags ongoing headwinds. Monitor architectural mix %—if it stays at 25%, the shift is structural; if it dips below 20%, Q1's 25% was aided by seasonal mix.
4 · GHS studio ramp and unit economics
Progress toward 50 studios by FY27 end. Any disclosure on revenue-per-studio and capex-per-studio will signal the path to profitability and scalability of the D2C model.
5 · TPU commissioning status
TPU line due Oct–Dec 2026 (Q3). Any color on customer pre-orders, trial results, or market traction will de-risk the market-creation thesis and hint at FY28 margin uplift.
The market's verdict is in the tape. The stock dropped 4.98% on day 1 post-result announcement, recovered to down 4.33% by day 3, then partially recovered to down 1.48% by day 5. A near-5% initial sell-off on a beat is a signal of skepticism, not indifference. What's the market saying? That Q1 margins are too good to be true, that supply-chain recovery is uncertain, and that management's disciplined guidance-hold is a yellow flag—not a sign of prudence, but of caution they're not willing to hide. Ownership data confirms modest institutional reception: FII ownership ticked up 24 basis points QoQ to 4.22%, and DII added 108 basis points to 6.35%, but these are modest increments on a record quarter. No institution is showing aggressive conviction. Promoter holding is steady at 60.72%. At ₹7,088 (as of Aug 14), the stock trades 11.28% below its all-time high of ₹7,990, above its 20-day and 50-day moving averages, but below the cyclical ceiling. The drawdown is modest, not panic. This is a stock priced for steady execution, not surprise beats—and the market is skeptical that Q1 beat will repeat.
Garware's Q1 is genuine: ₹633 crore revenue, a record, driven by product-mix shift (architectural, premium sun control) and capex maturation. Management is not sandbagging; they are disciplining execution. But the stock's 5% fade—and only partial recovery—reflects a truth management is stating clearly: this quarter is a seasonal peak, and margin headroom is narrower than the beat suggests.
The real story unfolds over the next 8–12 quarters: Can architectural films grow from 25% to 35–40% of mix? Can TPU backward integration deliver the promised 1.5–2% margin uplift in FY28? Can GHS scale from 9 to 50 studios without becoming a margin drag? These are execution bets. The quality of Garware's track record (debt-free, no prior guidance misses, capex on schedule) suggests yes. But the market's caution is earned.
Track Q2 EBITDA margin closely—it is the number that either validates the structural story or confirms the cyclical peak. At current valuation, the stock prices in 15–20% revenue CAGR (₹2,500 Cr FY27, ₹3,500 Cr in 3–4 years) and 25–26% normalized margins. Hit those, and the stock has room. Miss margin discipline or capex timelines, and the drawdown deepens. The honest read is one of steady execution, not a step-change. The test is Q2.
Garware Hi-Tech: record Q1 as consolidated PAT jumps 60% YoY to ₹133 Cr, margin hits 21%
PAT +59.79% YoY · revenue +27.9% · margins expanding · beat vs street
₹633.08 Cr
+27.9% YoY
₹132.65 Cr
+59.79% YoY
20.32%
+4pp YoY
₹57.1
Garware Hi-Tech Films posted its best-ever quarter on both counts: consolidated revenue of ₹633 Cr (+28% YoY, +6% QoQ) and PAT of ₹132.65 Cr (+60% YoY, +23% QoQ), with EBITDA of ₹192 Cr (+56% YoY) taking the EBITDA margin past 30% for the first time (30.3%, up 544 bps YoY and 404 bps QoQ) and PAT margin to 21.0% (up 418 bps YoY). Standalone PAT of ₹126.58 Cr trails the consolidated figure by about 5%, with the gap explained by profit from two overseas units — Garware Hi-Tech Films International and Global Hi-Tech Films Inc — which together earned ₹10.06 Cr on ₹267.47 Cr of revenue this quarter.
Q1 FY-2027 vs prior quarters
Management's own EBITDA bridge attributes the ₹69 Cr YoY EBITDA gain mostly to a ₹82 Cr operating-profit/volume-mix improvement and ₹6.3 Cr of other income, partly offset by ₹4.3 Cr higher employee cost and ₹17.8 Cr higher other expenses — consistent with the company's stated drivers of demand revival, improved realisations and a richer product mix across the architectural and automotive Sun Control Film and PPF lines. No exceptional or one-off items appear in either the current or year-ago quarter, so the 60% PAT growth is clean, organic expansion rather than a base-effect artefact.
The stock went into the print at ₹7,694.5, up 12.5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
D2C/capacity expansion — 14 new Global Application Studios added (3 Middle East, 11 US); domestic GAS at 250+, GHS at 9 (target 50 by FY27-end); TPU line on track for Q3 FY27, ₹191 Cr SCF line for H1 FY28
Management has issued strong guidance for FY27, targeting a minimum revenue of INR 2,500 crores and an EBITDA margin of 25% +/- 2%. This outlook is supported by a strategic focus on Direct-to-Consumer (D2C) initiatives like Garware Home Solutions, continued product innovation, and significant funded capacity expansions
— This quarter: beat
Against management's own FY27 guidance from the Q4 FY26 call — a minimum ₹2,500 Cr revenue and 25%±2% EBITDA margin — Q1's ₹633 Cr revenue annualises to roughly ₹2,532 Cr, tracking the floor, while the 30.3% EBITDA margin already sits well above the top of the guided band, an early beat on profitability even before the topline guidance is proven out. Street previews (Univest) had modelled Q1 FY27 revenue of ₹517-595 Cr and PAT of ₹102-129 Cr; the actual ₹633 Cr/₹133 Cr print beat both ranges. This confirms the bullish, confident tone management struck on the prior call. The quarter also carried DGTR's recommendation of anti-dumping duty on Chinese TPU-based PPF imports, which the company frames as a tailwind for its domestic PPF business, alongside board-level changes — Monika Garware's re-appointment as Vice-Chairperson & Joint MD (June 24) and Prashant Pai's appointment as interim CFO (announced with these results); Joint MD Sarita Garware Ramsay's passing on July 10 falls after the quarter-end and is unrelated to the print.
W1
TPU line commissioning reaffirmed for Q3 FY27 — watch for on-schedule startup and its margin contribution
W2
₹191 Cr Sun Control Film line (~1,200 LSF capacity) targeted for H1 FY28 commercial start — watch progress each quarter
W3
FY27 guidance (min ₹2,500 Cr revenue, 25%±2% EBITDA margin) — Q1 margin already above the guided band; watch whether it holds as volumes scale toward the revenue target